Heliyon (Jul 2024)

Global burden of bladder cancer attributable to smoking in 204 countries and territories, 1990–2019

  • Jixiang Yuan,
  • Lichen Chen,
  • Jielong Zhou,
  • Xinyue Zang,
  • Tongtong Zhang,
  • Xiran Ju,
  • Mingyue Tan,
  • Dongliang Xu

Journal volume & issue
Vol. 10, no. 13
p. e34114

Abstract

Read online

Bladder cancer (BCa) poses a significant medical burden worldwide. However, the epidemiological pattern of the global smoking-induced BCa burden is unclear. Our analysis of the 2019 Global Burden of Disease (GBD) database showed a significant increase in the number of BCa cases worldwide from 1990 to 2019, with a clear upward trend in both age-standardized prevalence and incidence. In contrast, age-standardized rates of mortality (ASMR) and disability-adjusted life-years (ASDR) showed a downward trend, despite an increase in the absolute number of death and disability-adjusted life years. The burden of BCa caused by smoking is greater in males, middle-aged and older adults, and people in countries with high-middle socio-demographic indices (SDI). The study highlights the continuing global health challenge posed by smoking-related BCa. Targeted health policies and interventions are critical, especially in areas with high smoking rates and low socioeconomic status.

Keywords